Grant-Huerta Yanina insider trades
Grant-Huerta Yanina has filed 7 Form 4s with the SEC that we hold, for Atara Biotherapeutics, Inc. (ATRA) (Chief Accounting Officer) and ImageneBio, Inc. (IMA) (Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 12 sales worth $92.5K reported on Form 4. In the last 12 months: 0 purchases ($0) and 8 sales ($56.5K). The largest single trade was a sale of 2,414 shares of Atara Biotherapeutics, Inc. worth $22.0K, dated 2026-05-18. The first filing on our record is dated 2025-05-20 and the latest 2026-08-17.
Atara Biotherapeutics, Inc. (ATRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-05-16 | S, sale reported on Form 4 | 2,218 | $15.0K | 2025-05-20 |
| 2025-08-18 | S, sale reported on Form 4 | 55 | $639 | 2025-08-20 |
| 2025-08-18 | S, sale reported on Form 4 | 86 | $998 | 2025-08-20 |
| 2025-08-18 | S, sale reported on Form 4 | 1,668 | $19.4K | 2025-08-20 |
| 2025-11-17 | S, sale reported on Form 4 | 1,645 | $21.7K | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 74 | $976 | 2025-11-19 |
| 2025-11-17 | S, sale reported on Form 4 | 85 | $1.1K | 2025-11-19 |
| 2026-03-02 | S, sale reported on Form 4 | 377 | $1.9K | 2026-03-04 |
| 2026-03-02 | S, sale reported on Form 4 | 1,603 | $8.1K | 2026-03-04 |
| 2026-03-02 | S, sale reported on Form 4 | 24 | $122 | 2026-03-04 |
| 2026-03-02 | S, sale reported on Form 4 | 100 | $508 | 2026-03-04 |
| 2026-05-18 | S, sale reported on Form 4 | 2,414 | $22.0K | 2026-05-20 |
ImageneBio, Inc. (IMA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 2064348) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms